Daytryp uses legal psychedelics to help heal patients
Let’s take a journey together. One where the mind has the opportunity to open and expand to places you never thought possible. A place where healing is the priority.
Daytryp Health opened the doors to their first Arizona office this week. They use legal psychedelic medicines and intertwine psychotherapy to attempt to create a healing experience for a variety of mental health conditions.
LEARN MORE: 4 most impactful skincare treatments for spring in Arizona
Founder and CEO Chris Cohn has previously worked in the drug and rehab space for 15 years and was unhappy with the results he saw.
“The majority of the people coming in didn't stay sober long term,” he says. “I just started seeking for a better way, and I came across the world of psychedelic medicine.”
The new office offers Ketamine Assisted Psychotherapies to help with various conditions including but not limited to addiction, chronic pain, anxiety, depression, trauma and PTSD. Ketamine treatments can be administered through an I.V. infusion or intramuscular shot.
At Daytryp, there is a particular focus put on integration of psychotherapy after a session which truly allows for the most healing. After a ketamine journey, the brain enters a state of neuroplasticity which allows clients to be more open to “new ideas and healthier ways of thinking,” Cohn explains.
Ketamine treatments at Daytryp are extremely personalized depending on a person’s physical health and the condition they are trying to treat, but the same basic appointment flow will apply to everyone.
During intake, a medical professional will check to make sure you are safe to go on your journey, decide on the dosage and type of ketamine treatment, and assign you a journey guide. The journey guide will be available throughout the entire session to assist you in setting intentions, keep an eye on you during your journey and review the session with you during the time of neuroplasticity.
"It's so important to have the integration, which is what we provide at Daytryp,” Cohn says. “To make sure that during this time of neuroplasticity that the folks are really doing what's suggested in terms of attempting to get healed.”
Cohn and his team have created a cozy and safe environment for clients to have the best journey possible and be able to heal. “Set and setting” are high priorities at Daytryp as they recognize that ketamine is only helpful when used in a safe manner.
Rooms are designed with soft beds covered in blankets and pillows for clients to relax in. During a journey, clients lay with their eyes covered with a sleep mask and use noise canceling headphones because the senses are often heightened. After a session, clients are brought a tray of tea and snacks if wanted during the journey review.
The length of a treatment will vary per person, so the Daytryp Team provides lots of time for clients to be able to rest and come out of their journey. They have created a comfortable living room space for post treatment relaxation should a client need more time after the journey review.
The Daytryp team recognized some of the struggles with getting ketamine treatments and have plans to help.
Treatments can be quite expensive since they are not yet recognized by any kind of insurance, so Daytryp has created payment plans that will assist in allowing clients to get the help they need.
Also, clients can't drive for four or five hours after their treatment, so it is recommended to have a friend or family member take you to and from your appointment. If a client doesn’t have anyone available to help, Daytryp offers a shuttle service for an additional fee.
Right now, Daytryp only has its Phoenix office open in Arcadia, but Cohn also has plans to open an office in Bend, Oregon in January 2024 as well as to open four other Arizona locations in Mesa, North Scottsdale, Tucson and Sedona in the next few years.
“Our goal is to prove this concept and grow from here,” he says.
Cohn’s inspiration for Daytryp first stemmed from his previous work in the drug and rehab space, but also came from his own journey with psychedelic medicine. He found healing through his use of Psilocybin therapies which will be available at the Oregon location.
Due to its early history as a recreational drug often called “Special K” or “Vitamin K,” Ketamine among other psychedelic medicines have a large stigma around them; however, recent studies have shown validity to the use of these products in controlled medical environments.
Cohn himself has seen clients leave with whole new perspectives. “Maybe the experience isn't for everybody, but anybody who came in thus far and experienced this kind of treatment has had a profound experience, life changing experience.”
Daytryp aims to break down the stigma behind these types of treatments and Cohn hopes that one day they will be able to “offer this type of treatment to the masses,” he says. “I believe it’s the future of mental health care.”